Navamedic's rights issue oversubscribed, secures NOK 130m

Navamedic ASA successfully concluded its partly underwritten rights issue, which was oversubscribed by approximately 7% at the maximum deal size of NOK 130 million. The company received valid subscriptions for 6,473,136 offer shares, exceeding the 6,046,511 available at a subscription price of NOK 21.50 per share.

The board of directors allocated 6,046,511 offer shares, generating gross proceeds of NOK 130 million. Of these, 1,982,319 shares were allocated to subscribers exercising rights, while 4,064,192 shares went to oversubscribing shareholders. Underwriters were not allocated shares in their capacity as such.

Additionally, Navamedic will issue 272,090 underwriting commission shares to underwriters for their services, at the same NOK 21.50 per share price. Following these issuances, the company's share capital will be NOK 17,746,219.72, divided into 23,981,378 shares. The new shares are expected to be tradable on Euronext Oslo Børs from October 14, 2025.